Skip to main content
Clinical Trials/ACTRN12621000389808
ACTRN12621000389808
Completed
未知

Randomised Controlled Trial of a tinnitus treatment platform based on Personalised Sound Therapy on tinnitus severity compared to a popular tinnitus treatment mobile application.

The University of Auckland0 sites99 target enrollmentApril 8, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Tinnitus
Sponsor
The University of Auckland
Enrollment
99
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This randomized single-blind controlled trial tested the hypothesis that a prototype digital therapeutic developed to provide goal-based counseling with personalized passive and active game-based sound therapy would provide superior tinnitus outcomes, and similar usability, to a popular passive sound therapy app over a 12 week trial period. The digital therapeutic (USL) consisted of an app for iPhone or Android smartphone, Bluetooth bone conduction headphones, neck pillow speaker, and a cloud-based clinician dashboard to enable messaging and app personalization. The control app was a popular self-help passive sound therapy app called White Noise Lite (WN). The USL group demonstrated a higher proportion of responders than the WN group. The usability of the USL therapeutic was similar to the established WN app. The digital polytherapeutic demonstrated significant benefit for tinnitus reduction supporting further development.

Registry
who.int
Start Date
April 8, 2021
End Date
March 19, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • .Adults with continuous chronic tinnitus (\> 6 months, Tinnitus Functional Index, TFI \> 40 \[Moderate to high Tinnitus handicap] no prior treatment history, loud sound does not worsen tinnitus, stress makes tinnitus worse) will be recruited from the general tinnitus population of Auckland.

Exclusion Criteria

  • Participants unable or unwilling to use a Smartphone app.
  • Persons without tinnitus.

Outcomes

Primary Outcomes

Not specified

Similar Trials